COVID-19: The Latest Information from UPMC
Children's Hospital is part of the UPMC family.
Be safe anytime, anywhere.
To find a pediatrician or pediatric specialist, please call 412-692-7337 or search our directory.
A resource for our network of referring physicians.
For more information about research, please call our main office at 412-692-6438.
Ranked #8 Nationally by U.S. News & World Report.
The purpose of this multicenter study is to learn about the investigational drug midazolam and its impact on control of seizure clusters when taken as a nasal spray by adolescents and adults with epilepsy. When given intravenously, midazolam is approved for use as an anesthetic and sedative, and researchers believe the liquid formulation of intranasal midazolam (USL261) may be effective for treatment of seizure cluster episodes. The study sponsors have nicknamed this study ARTEMIS-1, for Acute Rescue Therapy in Epilepsy with Midazolam Intranasal Spray-1.
Subject to certain exclusion criteria, the study is accepting people of both genders, ages 12 and older, who have a diagnosis of epilepsy that includes a history of seizure clusters occurring in an observable pattern. Participants must have an adult caregiver who can recognize and observe the participant’s seizure cluster episode.
Males and Females: Ages 12 years and older
At the initial screening visit, participants will receive a medical exam, including blood tests, and a patient management plan will be initiated. Participants will return to the study center for a second visit in which test doses of midazolam will be administered under observation by the research team. At the third study visit, each participant will be provided with a kit containing either two doses of the study drug or a placebo dose and a dose of the study drug. The kit is to be taken home and administered by the caregiver when a seizure cluster occurs, in accordance with instructions provided by the research team. The fourth and final visit occurs within 1 to 5 days of when the study drug was administered for seizure treatment.
Duration: Up to 8 months
Study Description at National Institutes of Health
Pediatric Epilepsy Center at Children’s Hospital of Pittsburgh of UMPC
Inna Ilana Vaisleib, MD
For more information about the study or enrollment, please contact:
Jennifer Monahan, Clinical Research Coordinator
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
UPMC Children’s Hospital of Pittsburgh
One Children’s Hospital Way
4401 Penn Ave.
Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With myCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Support the hospital by making a donation online, joining our Heroes in Healing monthly donor program, or visiting our site to learn about the other ways you can give back.